Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective study.
de Sousa LG, Liu S, Bhosale P, Altan M, Darbonne W, Schulze K, Dervin S, Yun C, Mahvash A, Verma A, Futreal A, Gite S, Cuentas EP, Cho WC, Wistuba I, Yao JC, Woodman SE, Halperin DM, Ferrarotto R.
de Sousa LG, et al. Among authors: yao jc.
Oral Oncol. 2024 Apr;151:106747. doi: 10.1016/j.oraloncology.2024.106747. Epub 2024 Mar 8.
Oral Oncol. 2024.
PMID: 38460288
No abstract available.